(283 days)
Not Found
No
The summary describes a standard multi-parameter patient monitor and does not mention any AI or ML capabilities, algorithms, or related concepts.
No
The device is described as a "Multi-parameter Patient Monitor" intended for "monitoring, reviewing and storing of multiple physiological parameters". It explicitly states it is "not intended to be used on the patients with pacemaker," and there is no mention of treating, rehabilitating, or diagnosing conditions in the provided text.
No
The device is described as a "Multi-parameter Patient Monitor" used for "monitoring, reviewing and storing of multiple physiological parameters." It provides real-time data on parameters like ECG, heart rate, respiration, SpO2, and NIBP. While this data can be used by healthcare professionals to inform diagnosis, the device itself is explicitly for monitoring and does not state that it provides a diagnosis.
No
The device description and performance studies clearly indicate this is a hardware device (Patient Monitor) that measures multiple physiological parameters using sensors and likely includes software for processing and displaying this data. The testing includes electrical safety, bench testing for specific physiological parameters, and clinical testing, all of which are indicative of a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is for "monitoring the physiological parameters of patients." It lists parameters like ECG, heart rate, respiration, temperature, SpO2, pulse rate, and non-invasive blood pressure. These are all measurements taken directly from the patient's body.
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Lack of Mention of Samples: The description and intended use do not mention the analysis of any biological samples.
Therefore, the C30 Multi-parameter Patient Monitor is a patient monitoring device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
C30 Multi-parameter Patient Monitor (hereinafter called Patient Monitor) is indicated for use by health care professionals whenever there is a need for monitoring the physiological parameters of patients. It's used for monitoring, reviewing and storing of multiple physiological parameters as following: ECG, heart rate (HR), respiration (Temp), SpO2, pulse rate (PR), non-invasive blood pressure (NIBP) of single patient. All parameters can be applied to adult, pediatric or neonate. The Patient Monitor is not intended to be used on the patients with pacemaker. The monitor is used for monitoring the clinical patients, so only the doctors and nurses who are qualified through training can use these monitors.
Product codes (comma separated list FDA assigned to the subject device)
DRT, DPS, DSJ, DSK, DXN, DOA, DSB, FLL
Device Description
C30 Multi-parameter Patient Monitor (hereinafter called Patient Monitor) is intended to be used for monitoring, reviewing and storing of multiple physiological parameters as following: ECG, heart rate (HR), respiration (Resp), temperature (Temp), SpO2, pulse rate (PR), non-invasive blood pressure (NIBP) of single patient. Other parameters can be applied to adult, pediatric or neonate.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult, Pediatric, Neonate
Intended User / Care Setting
Health care professionals, doctors and nurses who are qualified through training. Used for monitoring the clinical patients.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The C30 Multi-parameter Patient Monitor has been tested and found to be in compliance with recognized safety, performance and electromagnetic compatibility standards. The risk analysis has been developed to identify potential hazards and documents the mitigation of the hazards. The device's software has been verified and validated in accordance with the appropriate test requirements. Clinical and/or bench performance testing are also provided. The C30 Multi-parameter Patient Monitor has been evaluated by end-users and found to meets performed within its intended use and met their specific needs. The C30 Multi-parameter Patient Monitor has been tested and found to be in compliance with the following safety, performance and electromagnetic compatibility standards:
Electrical Safety and Electromagnetic Compatibility:
ANSI/AAMI ES60601-1:2005/(R)2012 and A1:2012, C1:2009/(R)2012 and A2:2010/(R)2012
IEC 60601-1-2:2007
Bench testing:
IEC 60601-1-8 Edition 2.0 2006-10
IEC60601-2-27 Edition 3.0 2011-03
IEC 80601-2-30 Edition 1.1 2013-07
IEC 80601-2-56 First Edition 2009-10-01
IEC 80601-2-61 First Edition 2011-04-01
IEC 62366-1 Edition 1.0 2015-01
ISO 80601-2-55 First Edition 2011-12-15
Clinical testing:
According to ISO 81060-2:2013, NIBP clinical accuracy was verified.
To verify respiration rate (RR) accuracy, Clinical study was conducted comparing the RR from the subject device with that from capnography.
Software Verification and Validation Testing:
The software was developed according to IEC 62304 First Edition 2006-05. Testing was conducted to verify and validate the software performs according to the requirements. Documentation in accordance with FDA's guidance document "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" was provided.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
August 16, 2018
Shenzhen Comen Medical Instruments Co., Ltd. Hongbo Yan Registration Engineer South of Floor 7, Block 5 4th Industrial Area of Nanyou Nanshan District Shenzhen, 518052 CN
Re: K173454
Trade/Device Name: Multi-parameter Patient Monitor, Model C30 Regulation Number: 21 CFR 870.2300 Regulation Name: Cardiac Monitor (Including Cardiotachometer and Rate Alarm) Regulatory Class: Class II Product Code: DRT, DPS, DSJ, DSK, DXN, DOA, DSB, FLL Dated: Julv 23, 2018 Received: July 23, 2018
Dear Hongbo Yan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE(@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Jessica E. Paulsen -S
for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K173454
Device Name
Multi-parameter Patient Monitor, Model C30
Indications for Use (Describe)
C30 Multi-parameter Patient Monitor (hereinafter called Patient Monitor) is indicated for use by health care professionals whenever there is a need for monitoring the physiological parameters of patients. It's used for monitoring, reviewing and storing of multiple physiological parameters as following: ECG, heart rate (HR), respiration (Temp), SpO2, pulse rate (PR), non-invasive blood pressure (NIBP) of single patient. All parameters can be applied to adult, pediatric or neonate. The Patient Monitor is not intended to be used on the patients with pacemaker.
The monitor is used for monitoring the clinical patients, so only the doctors and nurses who are qualified through training can use these monitors.
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510 (k) Summary C30 Multi-parameter Patient Monitor
This 510(k) Summary is provided in accordance with the requirements of 21 CER 807.92.
Date: | Aug 14, 2018 |
---|---|
Submitter: | SHENZHEN COMEN MEDICAL INSTRUMENTS CO.,LTD |
South of Floor 7, Block 5 4th Industrial Area of Nanyou, Nanshan District, | |
Shenzhen, Guangdong, 518052, P.R.China | |
No.2 of FIYTA Timepiece Building, Nanhuan Avenue, Gongming Sub-district, | |
Guangming New District, Shenzhen, Guangdong, 518106, P.R.China. | |
Contact: | Hongbo Yan |
Registration Engineer | |
Telephone: | +86-13424152596 |
Facsimile: | +86-755-26431232 |
Device Trade Name: | Multi-parameter Patient Monitor, Model C30 |
Common Name: | Multi-parameter Patient Monitor |
Device Classification:
Device Panel | Classification | ProCode | Description | |
---|---|---|---|---|
Cardiovascular | §870.2300, II | DRT | Cardiac Monitor (incl. Rate Alarm) | |
§870.1110, II | DSK | Computer, Blood Pressure | ||
Devices: | §870.1130, II | DXN | System, Measurement, Blood-Pressure, | |
Non-Invasive | ||||
§870.1100, II | DSJ | Alarm, Blood Pressure | ||
§870.2300, II | DRT | Monitor, Cardiac (incl. | ||
Cardiotachometer& Rate Alarm) | ||||
§870.2340, II | DPS | Electrocardiograph | ||
§870.2700, II | DQA | Oximeter | ||
§870.2770, IT | DSB | Plethysmograph, Impedance | ||
General Hospital | §880 .2910, II | FLL | Thermometer, Electronic, Clinical | |
Predicate Devices: | K123074, BeneView T1 Patient monitor, Shenzhen Mindray Bio-medical | |||
Electronics (The primary predicate device) | ||||
K112877, C80 COMEN Multi-parameter Patient Monitor, Shenzhen Comen | ||||
Medical Instruments Co., Ltd | ||||
Device description: | C30 Multi-parameter Patient Monitor (hereinafter called Patient Monitor) is | |||
intended to be used for monitoring, reviewing and storing of multiple physiological | ||||
parameters as following: ECG, heart rate (HR), respiration (Resp), temperature | ||||
(Temp), SpO2, pulse rate (PR), non-invasive blood pressure (NIBP) of single | ||||
patient. Other parameters can be applied to adult, pediatric or neonate. | ||||
Indications for Use: | C30 Multi-parameter Patient Monitor (hereinafter called Patient Monitor) is | |||
indicated for use by health care professionals whenever there is a need for | ||||
monitoring the physiological parameters of patients. It's used for monitoring, | ||||
reviewing and storing of multiple physiological parameters as following: ECG, | ||||
heart rate (HR), respiration (Resp), temperature (Temp), SpO2, pulse rate (PR), | ||||
non-invasive blood pressure (NIBP) of single patient. All parameters can be | ||||
applied to adult, pediatric or neonate. The Patient Monitor is not intended to be | ||||
used on the patients with pacemaker. The monitor is used for monitoring the | ||||
clinical patients, so only the doctors and nurses who are qualified through training | ||||
can use these monitors. | ||||
The table below lists the patient population for each parameter as appropriate: | ||||
Patient | ||||
Population | ||||
Parameter | Adult | Pediatric | Neonate | |
ECG | √ | √ | √ | |
RESP | √ | √ | √ | |
SpO2 | √ | √ | √ | |
TEMP | √ | √ | √ | |
NIBP | √ | √ | √ | |
Et CO2 | √ | √ | √ | |
Remark: | 1. The patient population for each parameter as | |||
appropriate is marked with '√'; |
- The neonatal patient type is not included in the
patient type of pediatrics for COMEN
multi-parameter patient monitors. | | |
| Indications for Use
Comparison to
Predicate Devices | The C30 and the predicate devices' indications for use are similar. The subject
and predicate devices are all patient monitors that are intended to be used in
healthcare facilities by physicians or clinical staff. The devices measure similar
patient parameters.
The device provides single patient monitoring for parameters such as ECG,
impedance respiration (Resp), temperature (TEMP),SpO2, pulse rate(PR),
noninvasive blood pressure (NIBP), respiration rate (RR) and EtCO2. All
parameters can be applied to adult, pediatric or neonate..
These minor differences between the predicate device and subject devices'
indications for use do not constitute a new intended use and are not significant
changes in indications for use. | | | |
| Technological
Comparison to
Predicate Devices: | Both the subject devices and the predicate devices provide a means for
interfacing with a patient, collecting parameter and specific physiological data,
and processing the data for alarm generation and display of numeric values and
waveforms. | | | |
4
5
6
Feature | Subject Devices | Predicate Device(primary) K123074 | Predicate Device K112877 | |||
---|---|---|---|---|---|---|
Dimension | C30 | T1 | C80 | |||
190×82×105mm | 143×77×102mm | 344.5x291×165 mm | ||||
Integrated | ||||||
display and | ||||||
touchscreen | 4.3" | |||||
480*272 pixels | 5" | |||||
same | 12.1" | |||||
800*600 pixels | ||||||
Power | ||||||
supply | One standard | |||||
rechargeable | ||||||
lithium-ion battery | ||||||
or AC power | Same | Same | ||||
Battery | 11.1V, 2600mAh | 14.8V, 4400Ah | 12V, 2500mAh | |||
ECG | 3-lead, 5-lead or | |||||
12-lead selectable, | 3-lead, 5-lead or | |||||
12-lead selectable, | ||||||
arrhythmia | ||||||
detection, ST | ||||||
segment | 3-lead, 5-lead or | |||||
12-lead | ||||||
selectable | ||||||
ECG | ||||||
measurement range and | ||||||
accuracy | HR: | |||||
Neonate / | ||||||
Pediatric: 15 to | ||||||
350bpm | ||||||
Adult: 15 to | ||||||
300bpm | ||||||
Accuracy: ±1% or | ||||||
±1bpm, whichever | ||||||
is the larger. | Same | Same | ||||
Respiration | ||||||
rate (Resp) | Measurement | |||||
range: Adult: 7 to | ||||||
120rpm, Neonate: | ||||||
7 to 150rpm. | ||||||
Accuracy: 7 to 150 | ||||||
rpm: ±2rpm or | ||||||
±2%, whichever is | ||||||
greater; 0 to 6rpm: | ||||||
Not specified. | Measurement | |||||
range: Adult: 0 to | ||||||
120rpm, Neonate: | ||||||
0 to 150rpm. | ||||||
Accuracy: same | Measurement | |||||
range: same | ||||||
Accuracy: | ||||||
7 to 150rpm: | ||||||
±1rpm | ||||||
Temperature | ||||||
(Temp) | Measurement | |||||
range: 0 to 50°C (32 | ||||||
to 122°F ) | ||||||
Accuracy: ±0.1 ℃ or | Same | Same | ||||
±0.2°F (without probe) | ||||||
Pulse oxygen saturation (SpO2) | Masimo SpO2 Module: | |||||
Measurement range: 1 to 100% | ||||||
Accuracy: 70 to 100%: ±2% (measured without motion in adult/pediatric mode) | ||||||
Accuracy: 70 to 100%: ±3% (measured without motion in neonate mode) | ||||||
Accuracy: 70 to 100%: ±3% (measured with motion) | ||||||
1 to 69%: Not specified | ||||||
NellcorSpO2 module: | ||||||
Measurement range: 0 to 100% | ||||||
Accuracy: 70 to 100%: ±2% (adult/pediatric mode) | ||||||
Accuracy: 70 to 100%: ±3% (neonate mode) | ||||||
0 to 69%: Not specified | MindraySpO2 Module: | |||||
Measurement range: 0 to 100% | ||||||
Accuracy: 70 to 100%: ±2% (adult/pediatric mode) | ||||||
70 to 100%: ±3% (neonate mode) | ||||||
0 to 69%: Not specified | ||||||
Masimo SpO2 Module: Same | ||||||
NellcorSpO2 module: Same | Masimo SpO2 Module: Same | |||||
NellcorSpO2 module: Same | ||||||
Pulse rate | PR from MasimoSpO2 module: | |||||
Measurement | PR from MindraySpO2 module: | |||||
Measurement | / | |||||
range: 25 to 240 | ||||||
bpm | ||||||
Accuracy: ±3bpm | ||||||
(measured without | ||||||
motion) | ||||||
±5 bpm (measured | ||||||
with motion) |
PR from
NellcorSpO2
module:
Measurement
range: 20 to 300
bpm
Accuracy: 20 to
250bpm: ±3bpm,
251 to 300bpm:not
specified. | range: 20 to 254
bpm
Accuracy: ±3bpm
PR from
MasimoSpO2
module: Same
PR from
NellcorSpO2
module: Same | | | |
| Non-invasive blood
pressure
(NIBP) | | Measurement
range:
Adult:
Systolic:
40-270mmHg
Mean: /
Diastolic:
10-215mmHg
Pediatric:
Systolic:
40-200mmHg
Mean: /
Diastolic:
10-150mmHg
Neonate:
Systolic:
40-135mmHg
Mean: /
Diastolic:
10-100mmHg
Accuracy:
Max mean error: | Measurement
range:
Adult:
Systolic: same
Mean: 20-230
Diastolic:
10-210mmHg
Pediatric:
Systolic: same
Mean:
20-165mmHg
Diastolic: same
Neonate:
Systolic: same
Mean:
20-110mmHg
Diastolic:
10-110mmHg
Accuracy: Same | Measurement
range:
Adult:
Systolic: same
Mean: 20-235
Diastolic: same
Pediatric:
Systolic: same
Mean:
20-165mmHg
Diastolic:
10-100mmHg
Neonate:
Systolic:
40-150mmHg
Mean:
20-110mmHg
Diastolic: same
Accuracy:
Same | | |
| | | | | | | |
| Carbon
dioxide
(CO2) | ±5mmHg | | / | | | |
| | Max standard
deviation: 8mmHg | | | | | |
| | Respironics
Novametrix CO2
module: | Measurement
range: 0-99mmHg | | | | |
| | Measurement
range:
0-150mmHg, | Accuracy: | | | | |
| | Accuracy: | 0 to 40 mmHg:
±2mmHg | | | | |
| | 0-40mmHg:
±2mmHg | 41 to 76mmHg:
±5% of the reading | | | | |
| | 41-70mmHg: ±5%
of the reading | 77 to 99mmHg:
±10% of the
reading | | | | |
| | 71-100mmHg: ±8%
of the reading | awRR
measurement
range: 0 to 120
rpm | | | | |
| | 101-150mmHg:
±10% of the
reading | awRR
measurement
accuracy: ±2rpm | | | | |
| | awRR
measurement
range: 0 to 150 rpm | | | | | |
| | awRR
measurement
accuracy: ±1rpm | | | | | |
| | | | | | | |
| | Masimo CO2
module: | | | | | |
| | Measurement
range: 0-190mmHg | | | | | |
| | Accuracy: | | | | | |
| | 0-114mmHg:
±1.52mmHg+2% | | | | | |
| | 114mmHg-190mm
Hg: Not specified | | | | | |
| | awRR
measurement
range: 0 to 150 rpm | | | | | |
| | awRR
measurement
accuracy: ±1rpm | | | | | |
| | | | | | | |
7
8
9
10
The differences do not raise questions of safety and effectiveness | |
---|---|
Summary of | |
Performance Testing: | The C30 Multi-parameter Patient Monitor has been tested and found to be in |
compliance with recognized safety, performance and electromagnetic | |
compatibility standards. | |
The risk analysis has been developed to identify potential hazards and | |
documents the mitigation of the hazards. The device's software has been verified | |
and validated in accordance with the appropriate test requirements. Clinical | |
and/or bench performance testing are also provided. | |
The C30 Multi-parameter Patient Monitor has been evaluated by end-users and | |
found to meets performed within its intended use and met their specific needs. | |
The C30 Multi-parameter Patient Monitor has been tested and found to be in | |
compliance with the following safety, performance and electromagnetic | |
compatibility standards: | |
Electrical Safety and Electromagnetic Compatibility: | |
ANSI/AAMI ES60601-1:2005/(R)2012 and A1:2012, C1:2009/(R)2012 and | |
A2:2010/(R)2012 | |
IEC 60601-1-2:2007 | |
Bench testing: | |
IEC 60601-1-8 Edition 2.0 2006-10 | |
IEC60601-2-27 Edition 3.0 2011-03 | |
IEC 80601-2-30 Edition 1.1 2013-07 | |
IEC 80601-2-56 First Edition 2009-10-01 | |
IEC 80601-2-61 First Edition 2011-04-01 | |
IEC 62366-1 Edition 1.0 2015-01 | |
ISO 80601-2-55 First Edition 2011-12-15 | |
Clinical testing: | |
According to ISO 81060-2:2013, NIBP clinical accuracy was verified. | |
To verify respiration rate (RR) accuracy, Clinical study was conducted comparing | |
the RR from the subject device with that from capnography. | |
Software Verification and Validation Testing: | |
The software was developed according to IEC 62304 First Edition 2006-05. | |
Testing was conducted to verify and validate the software performs according to | |
the requirements. Documentation in accordance with FDA's guidance document | |
"Guidance for the Content of Premarket Submissions for Software Contained in | |
Medical Devices" was provided. | |
Conclusion: | Based on similarities in intended use and technological characteristics, results of |
performance and validation/verification testing, and conformance with applicable | |
standards, the C30 Multi-parameter Patient Monitor is considered substantially | |
equivalent to the predicate devices. |
11